Search Results - "Walter, Canonica"

Biologics and airway remodeling in severe asthma by Varricchi, Gilda, Ferri, Sebastian, Pepys, Jack, Poto, Remo, Spadaro, Giuseppe, Nappi, Emanuele, Paoletti, Giovanni, Virchow, Johann Christian, Heffler, Enrico, Canonica, Walter G.

“…Asthma is a chronic inflammatory airway disease resulting in airflow obstruction, which in part can become irreversible to conventional therapies, defining the…”
Get full text

Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 Revision by Brożek, Jan L., MD, PhD, Bousquet, Jean, MD, PhD, Baena-Cagnani, Carlos E., MD, Bonini, Sergio, MD, Canonica, G. Walter, MD, Casale, Thomas B., MD, van Wijk, Roy Gerth, MD, PhD, Ohta, Ken, MD, PhD, Zuberbier, Torsten, MD, Schünemann, Holger J., MD, PhD, MSc

“…Background Allergic rhinitis represents a global health problem affecting 10% to 20% of the population. The Allergic Rhinitis and its Impact on Asthma (ARIA)…”
Get full text

Allergic rhinitis by Bousquet, Jean, Anto, Josep M., Bachert, Claus, Baiardini, Ilaria, Bosnic-Anticevich, Sinthia, Walter Canonica, G., Melén, Erik, Palomares, Oscar, Scadding, Glenis K., Togias, Alkis, Toppila-Salmi, Sanna

“…Allergic rhinitis (AR) is caused by immunoglobulin E (IgE)-mediated reactions to inhaled allergens and is one of the most common chronic conditions globally…”
Get full text

EAACI/GA²LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria by Zuberbier, T, Asero, R, Bindslev-Jensen, C, Walter Canonica, G, Church, M.K, Giménez-Arnau, A, Grattan, C.E.H, Kapp, A, Merk, H.F, Rogala, B, Saini, S, Sánchez-Borges, M, Schmid-Grendelmeier, P, Schünemann, H, Staubach, P, Vena, G.A, Wedi, B, Maurer, M

“…This guideline, together with its sister guideline on the management of urticaria [Zuberbier T, Asero R, Bindslev-Jensen C, Canonica GW, Church MK,…”
Get full text

Allergen Immunotherapy for the Prevention and Treatment of Asthma by Batard, Thierry, Taillé, Camille, Guilleminault, Laurent, Bozek, Andrzej, Floch, Véronique Bordas-Le, Pfaar, Oliver, Canonica, Walter G, Akdis, Cezmi, Shamji, Mohamed H, Mascarell, Laurent

“…Allergic asthma is the predominant phenotype among asthmatics. Although conventional pharmacotherapy is a central component in the management of asthma, it…”
Get full text

Handling of allergen immunotherapy in the COVID‐19 pandemic: An ARIA‐EAACI statement by Pfaar, Oliver, Klimek, Ludger, Jutel, Marek, Akdis, Cezmi, Bousquet, Jean, Akdis, Mübeccel, Bachert, Claus, Agache, Ioana, Ansotegui, Ignacio, Bedbrook, Anna, Bosnic‐Anticevich, Sinthia, Canonica, Giorgio W., Chivato, Tomas, Cruz, Alvaro A., Czarlewski, Wienia, Del Giacco, Stefano, Du, Hui, Fonseca, Joao A., Gao, Yadong, Haahtela, Tari, Hoffmann‐Sommergruber, Karin, Ivancevich, Juan‐Carlos, Khaltaev, Nikolai, Knol, Edward F., Kuna, Piotr, Larenas‐Linnemann, Desiree, Melen, Erik, Mullol, Joaquim, Naclerio, Robert, Ohta, Ken, Okamoto, Yoshitaka, O’Mahony, Liam, Onorato, Gabrielle L, Papadopoulos, Nikos G., Pawankar, Ruby, Samolinski, Boleslaw, Schwarze, Jurgen, Toppila‐Salmi, Sanna, Shamji, Mohamed H., Teresa Ventura, Maria, Valiulis, Arunas, Yorgancioglu, Arzu, Matricardi, Paolo, Zuberbier, Torsten

“…The current COVID‐19 pandemic influences many areas of social life, medical treatments and the way allergy is performed. Allergen‐specific immunotherapy (AIT)…”
Get full text

Standardized quality (SQ) house dust mite sublingual immunotherapy tablet (ALK) reduces inhaled corticosteroid use while maintaining asthma control: A randomized, double-blind, placebo-controlled trial by Mosbech, Holger, MD, Deckelmann, Regina, MD, de Blay, Fréderic, MD, Pastorello, Elide Anna, MD, Trebas-Pietras, Ewa, MD, Andres, Luis Prieto, MD, Malcus, Inga, MD, Ljørring, Christian, MSc, Canonica, Giorgio Walter, MD

“…Background Investigations meeting current standards are limited for the effect of house dust mite (HDM) allergy immunotherapy in asthmatic patients. Objective…”
Get full text

COVID‐19  vaccination in patients receiving allergen immunotherapy (AIT) or biologicals—EAACI recommendations by Jutel, Marek, Torres, Maria J., Palomares, Oscar, Akdis, Cezmi A., Eiwegger, Thomas, Untersmayr, Eva, Barber, Domingo, Zemelka‐Wiacek, Magdalena, Kosowska, Anna, Palmer, Elizabeth, Vieths, Stefan, Mahler, Vera, Canonica, Walter G., Nadeau, Kari, Shamji, Mohamed H, Agache, Ioana

“…Immune modulation is a key therapeutic approach for allergic diseases, asthma and autoimmunity. It can be achieved in an antigen‐specific manner via allergen…”
Get full text

Long-lasting effects of sublingual immunotherapy according to its duration: A 15-year prospective study by Marogna, Maurizio, MD, Spadolini, Igino, MD, Massolo, Alessandro, BS, Canonica, Giorgio Walter, MD, Passalacqua, Giovanni, MD

“…Background Data on the long-term effects of sublingual immunotherapy (SLIT) are sparse, and the optimal duration of treatment is a matter of debate. Objective…”
Get full text

International consensus on allergy immunotherapy by Jutel, Marek, MD, Agache, Ioana, MD, Bonini, Sergio, MD, Burks, A. Wesley, MD, Calderon, Moises, MD, Canonica, Walter, MD, Cox, Linda, MD, Demoly, Pascal, MD, Frew, Antony J., MD, O'Hehir, Robin, MD, Kleine-Tebbe, Jörg, MD, Muraro, Antonella, MD, Lack, Gideon, MD, Larenas, Désirée, MD, Levin, Michael, MD, Nelson, Harald, MD, Pawankar, Ruby, MD, Pfaar, Oliver, MD, van Ree, Ronald, PhD, Sampson, Hugh, MD, Santos, Alexandra F., MD, PhD, Du Toit, George, MD, Werfel, Thomas, MD, Gerth van Wijk, Roy, MD, Zhang, Luo, MD, Akdis, Cezmi A., MD

“…Allergen immunotherapy (AIT) has been used to treat allergic disease since the early 1900s. Despite numerous clinical trials and meta-analyses proving AIT…”
Get full text

Face masks, respiratory patients and COVID-19 by Soriano, Joan B, Anzueto, Antonio, Bosnic Anticevich, Sinthia, Kaplan, Alan, Miravitlles, Marc, Usmani, Omar, Papadopoulos, Nikolaos G, Puggioni, Francesca, Canonica, G Walter, Roche, Nicolas

“…Several countries have applied exemptions of respiratory patients on the compulsory use of face masks indoors and outdoors during the coronavirus disease 2019…”
Get full text

Corrigendum to “Manifesto on small airway involvement and management in asthma and chronic obstructive pulmonary disease: an Interasma (Global Asthma Association - GAA) and World Allergy Organization (WAO) document endorsed by Allergic Rhinitis and its Impact on Asthma (ARIA) and Global Allergy and Asthma European Network (GA2LEN)” [World Allergy Organ (2016) 9-37] by Walter Canonica, G.

“…[This corrects the article DOI: 10.1186/s40413-016-0123-2.]…”
Get full text

How adherent to sublingual immunotherapy prescriptions are patients? The manufacturers' viewpoint by Senna, Gianenrico, MD, Lombardi, Carlo, MD, Canonica, Giorgio Walter, MD, Passalacqua, Giovanni, MD

“…[...]in the case of SLIT, medical supervision is usually limited to control visits or to prescription renewals. [...]sales data provided by manufacturers show…”
Get full text

Coordinated IgG2 and IgE responses as a marker of allergen immunotherapy efficacy by Bordas‐Le Floch, Véronique, Berjont, Nathalie, Batard, Thierry, Varese, Nirupama, O’Hehir, Robyn E., Canonica, Walter G, Zelm, Menno C., Mascarell, Laurent

“…Background IgG2 responses are associated with repeated antigen exposure and display highly mutated variable domains. A recent study highlighted a role of IgG2+…”
Get full text

Current advances in house dust mite allergen immunotherapy (AIT): Routes of administration, biomarkers and molecular allergen profiling by Batard, Thierry, Canonica, Walter G., Pfaar, Oliver, Shamji, Mohamed H., O’Hehir, Robyn E., van Zelm, Menno C., Mascarell, Laurent

“…Allergy to house dust mites (HDM) is a perennial respiratory disease that affect more than half a billion people worldwide. Dermatophagoides pteronyssinus and…”
Get full text

Impact of baseline patient characteristics on dupilumab efficacy in type 2 asthma by Busse, William W., Paggiaro, Pierluigi, Muñoz, Xavier, Casale, Thomas B., Castro, Mario, Canonica, G. Walter, Douglass, Jo A., Tohda, Yuji, Daizadeh, Nadia, Ortiz, Benjamin, Pandit-Abid, Nami

“…Severe asthma affects an estimated 5–10% of the total asthma patient population [1]. Various demographic factors, such as sex, age, obesity and age of onset,…”
Get full text

Rhinitis: adherence to treatment and new technologies by Braido, Fulvio, Baiardini, Ilaria, Puggioni, Francesca, Garuti, Silvia, Pawankar, Ruby, Walter Canonica, G

“…PURPOSE OF REVIEWNonadherence to treatment is a major issue in approximately 50% of patients suffering from chronic diseases. The availability of new…”
Get full text

Early increase in serum specific IgG2 upon allergen immunotherapy with a 300 IR sublingual house dust mite tablet by Berjont, Nathalie, Floch, Véronique V Bordas‐Le, O'Hehir, Robyn E., Canonica, Walter G., Zelm, Menno C., Batard, Thierry, Mascarell, Laurent

Get full text

Correlation of serum vitamin D concentration with humoral‐specific IgG2 and IgG4 levels in high responders to immunotherapy with a 300 IR sublingual house dust mite tablet by Fernandez, José Carlos, Luce, Sonia, Floch, Véronique Bordas‐Le, Canonica, Walter G., Batard, Thierry, Mascarell, Laurent

Get full text

Climate change, air pollution and extreme events leading to increasing prevalence of allergic respiratory diseases by D'Amato, Gennaro, Baena-Cagnani, Carlos E, Cecchi, Lorenzo, Annesi-Maesano, Isabella, Nunes, Carlos, Ansotegui, Ignacio, D'Amato, Maria, Liccardi, Gennaro, Sofia, Matteo, Canonica, Walter G

“…The prevalence of asthma and allergic diseases has increased dramatically during the past few decades not only in industrialized countries. Urban air pollution…”
Get full text